Concepedia

Todd C. Skaar

TC

Statistics

Publications

149

Citations

10.8K

H-Index

51

Active since

1989

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

University of Michigan

Johns Hopkins University

University of Florida

Todd C. Skaar is an author at Indiana University – Purdue University Indianapolis specializing in medicine, pharmacology, and pharmacogenetics.

ORCID

Publications per year

1989–2024

149

Publications

149

CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment

Zeruesenay Desta, Vered Stearns, Brent B. Ward et al. · JNCI Journal of the National Cancer Institute · 2005 · 942 citations · Full text

, , +17

Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger et al. · Clinical Pharmacology & Therapeutics · 2014 · 678 citations · Full text

, , +17

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment

Sandra Regina de Oliveira Borges, Zereunesay Desta, L LI et al. · Clinical Pharmacology & Therapeutics · 2006 · 479 citations · Full text

, , +17

Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen

Michael D. Johnson, Hong Zuo, Kyung-Hoon Lee et al. · Breast Cancer Research and Treatment · 2004 · 455 citations

, , +16

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

J. Kevin Hicks, Jesse J. Swen, Caroline F. Thorn et al. · Clinical Pharmacology & Therapeutics · 2013 · 453 citations · Full text

, , +17

1–5 of 149